Avinger Announces Expanded FDA Indications for Pantheris™ as Diagnostic Imaging Device
October 19, 2016 16:01 ET
|
Avinger Inc
REDWOOD CITY, Calif., Oct. 19, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced that the...
Avinger Signs Agreement with U.S. Department of Veterans Affairs for Lumivascular Technology
September 13, 2016 16:01 ET
|
Avinger Inc
REDWOOD CITY, Calif., Sept. 13, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a developer of innovative treatments for peripheral artery disease (PAD), today announced the company has...
Avinger Signs Agreement with HealthTrust for Lumivascular Technology
September 07, 2016 16:01 ET
|
Avinger Inc
REDWOOD CITY, Calif., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a developer of innovative treatments for peripheral artery disease (PAD), today announced it has signed an...
Avinger, Inc. Announces Closing of Public Offering of Common Stock and Underwriters’ Full Exercise of Option to Purchase Additional Shares
August 16, 2016 16:01 ET
|
Avinger Inc
REDWOOD CITY, Calif., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today...
Avinger, Inc. Announces Pricing of Public Offering of Common Stock
August 11, 2016 08:30 ET
|
Avinger Inc
REDWOOD CITY, Calif., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today...
Avinger, Inc. Announces Proposed Public Offering of Common Stock
August 10, 2016 16:05 ET
|
Avinger Inc
REDWOOD CITY, Calif., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today...
Avinger, Inc. Announces Participation in Canaccord Genuity 36th Annual Growth Conference
August 09, 2016 07:30 ET
|
Avinger Inc
REDWOOD CITY, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the...
Avinger, Inc. Announces Second Quarter 2016 Results
August 01, 2016 16:01 ET
|
Avinger Inc
REDWOOD CITY, Calif., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today...
Avinger, Inc. to Announce Second Quarter 2016 Results on Monday, August 1, 2016
July 25, 2016 16:01 ET
|
Avinger Inc
REDWOOD CITY, Calif., July 25, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will...
Avinger, Inc. Announces Preliminary Second Quarter 2016 Revenue Results
July 12, 2016 16:01 ET
|
Avinger Inc
REDWOOD CITY, Calif., July 12, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that based on...